Intelligent Bio Solutions Inc. (INBS)
NASDAQ (CM) NASDAQ (CM) Primary Summary
INBS Stock Surges 132.4% on New Manufacturing Partnership
Intelligent Bio Solutions' stock jumps after a new manufacturing partnership aimed at cutting costs, boosting margins and scaling production ahead of U.S. expansion.
INBS Stock May Rise on SMARTOX Partnership Expanding Forensic Reach
Intelligent Bio Solutions collaborates with SMARTOX to expand U.S. forensic reach, boosting its drug test tech and eyeing FDA clearance for growth.
Intelligent Bio Solutions Stock Drops Despite Key U.S. Patent Win
INBS secures a key U.S. patent, strengthening its IP protection and paving the way for 2025 market entry with innovative biometric technology.
Intelligent Bio Solutions Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Anthony Scaramucci SkyBridge Capital II LLC | 130,000 | $434,850 | $304,850 | -$130,000 | -29.9% |
 Lyn Dippel Curio Wealth LLC | 200 | $1,906 | $439 | -$1,467 | -76.97% |
Intelligent Bio Solutions Inc. (INBS) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Intelligent Bio Solutions Inc. ever had a stock split?
Intelligent Bio Solutions Inc. Profile
| Professional Services Industry | Industrials Sector | Harry Simeonidis CEO | NASDAQ (CM) Exchange | 36151G709 CUSIP |
| US Country | 50 Employees | - Last Dividend | 16 Dec 2025 Last Split | 23 Dec 2020 IPO Date |
Overview
Intelligent Bio Solutions Inc. stands as a pioneering medical technology enterprise, focused on the innovation of non-invasive, real-time monitoring and diagnostic tests tailored for both patients and their primary health practitioners. Initially known as GBS Inc., the company underwent a rebranding to its current name in October 2022, marking a significant milestone in its evolution. Founded in 2016 and operating out of New York, New York, Intelligent Bio Solutions Inc. functions under the umbrella of Life Science Biosensor Diagnostics Pty Ltd., signifying its strong backing and strategic alignment with leading biosensor technologies. This close association underpins its mission to transform patient care through groundbreaking diagnostic tools.
Products and Services
-
Saliva Glucose Biosensor for Diabetes Management:
This innovative product is at the forefront of Intelligent Bio Solutions Inc.'s offerings. It is designed to measure glucose levels in saliva, providing a non-invasive alternative to traditional blood glucose monitoring systems. This technology caters to the needs of individuals with diabetes, aiming to simplify and enhance their disease management protocols.
-
Intelligent Fingerprinting Drug Screening System:
Representing a significant leap forward in drug testing, this system conducts screening through fingerprint sweat analysis. Portable and efficient, the technology not only promises advancements in drug detection but also holds the potential for widespread use in various other applications due to its versatility and ease of use.
-
Biosensor Platform:
At its core, Intelligent Bio Solutions Inc. is developing a comprehensive biosensor platform capable of supporting a broad spectrum of diagnostic tests. This platform encompasses biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. By covering a wide range of testing capabilities, the company aspires to cater to diverse diagnostic needs, thereby laying the groundwork for future innovations in medical diagnostics.
